Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 6 studies | 27% ± 13% | |
glutamatergic neuron | 5 studies | 41% ± 17% | |
cardiac muscle cell | 5 studies | 21% ± 5% | |
retinal cone cell | 4 studies | 21% ± 8% | |
endothelial cell | 3 studies | 21% ± 2% | |
GABAergic neuron | 3 studies | 37% ± 7% | |
ependymal cell | 3 studies | 39% ± 6% | |
interneuron | 3 studies | 45% ± 21% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 750.11 | 1803 / 1809 | 100% | 22.11 | 470 / 472 |
thymus | 100% | 903.11 | 652 / 653 | 99% | 13.82 | 599 / 605 |
kidney | 100% | 667.63 | 89 / 89 | 99% | 13.28 | 888 / 901 |
uterus | 100% | 2261.96 | 170 / 170 | 98% | 14.89 | 451 / 459 |
breast | 100% | 1071.37 | 459 / 459 | 98% | 11.00 | 1097 / 1118 |
esophagus | 100% | 574.67 | 1443 / 1445 | 97% | 9.55 | 177 / 183 |
lung | 100% | 677.92 | 576 / 578 | 97% | 10.33 | 1116 / 1155 |
bladder | 100% | 515.48 | 21 / 21 | 96% | 10.14 | 485 / 504 |
pancreas | 98% | 371.72 | 323 / 328 | 98% | 9.04 | 174 / 178 |
intestine | 100% | 629.78 | 966 / 966 | 96% | 8.47 | 506 / 527 |
prostate | 100% | 675.77 | 245 / 245 | 95% | 6.57 | 479 / 502 |
brain | 94% | 971.07 | 2485 / 2642 | 100% | 25.07 | 703 / 705 |
stomach | 100% | 613.74 | 359 / 359 | 91% | 8.12 | 260 / 286 |
ovary | 100% | 929.93 | 180 / 180 | 84% | 5.57 | 363 / 430 |
liver | 97% | 325.47 | 220 / 226 | 75% | 4.79 | 303 / 406 |
adrenal gland | 98% | 432.92 | 254 / 258 | 57% | 3.42 | 130 / 230 |
adipose | 100% | 759.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1165.60 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 628.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.83 | 1 / 1 |
heart | 99% | 1718.29 | 854 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 20.97 | 77 / 80 |
muscle | 93% | 376.92 | 748 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 5.74 | 26 / 29 |
peripheral blood | 19% | 43.68 | 177 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006004 | Biological process | fucose metabolic process |
GO_0036066 | Biological process | protein O-linked fucosylation |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0008375 | Molecular function | acetylglucosaminyltransferase activity |
GO_0016757 | Molecular function | glycosyltransferase activity |
Gene name | B3GLCT |
Protein name | Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like) |
Synonyms | B3GALTL B3GTL |
Description | FUNCTION: O-glucosyltransferase that transfers glucose toward fucose with a beta-1,3 linkage. Specifically glucosylates O-linked fucosylglycan on TSP type-1 domains of proteins, thereby contributing to elongation of O-fucosylglycan. . |
Accessions | Q6Y288 ENST00000343307.5 |